Attached files
file | filename |
---|---|
EX-10.2D - EX-10.2.(D) - Imago BioSciences, Inc. | d143204dex102d.htm |
EX-10.2C - EX-10.2.(C) - Imago BioSciences, Inc. | d143204dex102c.htm |
EX-10.2B - EX-10.2.(B) - Imago BioSciences, Inc. | d143204dex102b.htm |
EX-10.2A - EX-10.2.(A) - Imago BioSciences, Inc. | d143204dex102a.htm |
EX-10.1 - EX-10.1 - Imago BioSciences, Inc. | d143204dex101.htm |
EX-3.4 - EX-3.4 - Imago BioSciences, Inc. | d143204dex34.htm |
EX-3.1 - EX-3.1 - Imago BioSciences, Inc. | d143204dex31.htm |
S-1 - S-1 - Imago BioSciences, Inc. | d143204ds1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated April 5, 2021, relating to the financial statements of Imago BioSciences, Inc. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ Deloitte & Touche LLP |
San Francisco, California
June 25, 2021